XBiotech Inc.
XBIT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001626878
No open-market purchases or sales by XBiotech Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $4.56M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding XBiotech Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 39 | 46 | +7 |
| Shares | 3.45M | 3.99M | +548.0K (+15.9%) |
| Value | $13.8M | $32.5M | +$18.7M (+135.5%) |
New holders (10)
Institutions that held XBiotech Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Goldman Sachs Group Inc | 62,161 | $505.4K | 0.00% |
| Marshall Wace, LLP | 54,679 | $444.5K | 0.00% |
| HRT Financial LP | 33,593 | $273.0K | 0.00% |
| Point72 Asia (Singapore) Pte. Ltd. | 25,954 | $211.0K | 0.05% |
| Balyasny Asset Management LLC | 21,865 | $177.8K | 0.00% |
| Brevan Howard Capital Management LP | 20,578 | $167.3K | 0.02% |
| Y-Intercept (Hong Kong) Ltd | 18,043 | $146.7K | 0.01% |
| ExodusPoint Capital Management, LP | 16,177 | $132.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 5,254 | $42.7K | 0.00% |
| Macquarie Group Ltd | 576 | $5 | 0.00% |
Sold out (3)
Institutions that held XBiotech Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Man Group plc | 58,355 | $233.4K |
| Squarepoint Ops LLC | 18,922 | $75.7K |
| LGT Fund Management Co Ltd. | 10,000 | $39.7K |